Top compounds associated with response to SLC22A16


Feature Type Standardized
Nominal ANOVA
mRNA BHG712 GDSC1000 pan-cancer AAC 0.13 1e-05
mRNA KIN001-244 GDSC1000 pan-cancer AAC 0.14 1e-05
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.15 2e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA PD-0325901 CCLE pan-cancer AAC 0.18 5e-05
mRNA barasertib CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA quizartinib CTRPv2 pan-cancer AAC 0.15 6e-05
Download CSV